BioSpace News Archive

Deals

Centinel Spine Completes Acquisition of Prodisc Assets

Centinel Spine is pleased to announce the acquisition of the worldwide assets of the prodisc Total Disc Replacement portfolio from DePuy Synthes The prodisc line of products are total disc replacement products with the longest history of use globally.

December 22, 2017

·

3 min read

Pharm Country

Tauriga Sciences Extinguishes its Largest Remaining Balance Sheet Liability for One Time Cash Payment of $15,000 and One Time Issuance of 5,000,000 Restricted Shares; Liability Dated Back to the Years 2010/2011 and Totaled $177,883.71

This Accounts Payable liability totaled $177,883.71 and the creditor was a U.S. based Environmental Engineering firm.

December 22, 2017

·

4 min read

Business

Haemonetics Sets Date for Publishing Third Quarter Fiscal 2018 Results: February 6, 2018

Haemonetics announced that the Company intends to publish third quarter fiscal 2018 financial results at 6:00 am Eastern Time on Tuesday, February 6, 2018.

December 22, 2017

·

1 min read

Business

Roche and Accenture Collaborate to Enhance Digital Healthcare for Cancer Patients

Under the terms of this exclusive multi-year agreement, Accenture will provide digital data integration services to Roche’s NAVIFY Tumor Board solution.

December 22, 2017

·

2 min read

Pharm Country

John Theurer Cancer Center Release: Pivotal CAR-T Therapy Cancer Study Published in the New England Journal of Medicine

John Theurer Cancer Center at Hackensack University Medical Center is the only New Jersey center that participated in a pivotal clinical trial of a groundbreaking cancer treatment, CAR-T Cell therapy, which genetically modifies a patient’s immune system to attack cancer cells.

December 22, 2017

·

5 min read

Orchard Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

Orchard Therapeutics today announced that Mark Rothera, president and CEO, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 9, 2018 at 3:00 p.m. PT.

December 22, 2017

·

1 min read

Pharm Country

Akers Bio Announces Closing of $6,900,000 Public Offering

The funds raised will be used for working capital, product development, marketing activities, expanding our internal sales organization and further developing sales channels and other capital expenditures.

December 22, 2017

·

4 min read

FDA

Bausch & Lomb Receives FDA Approval of LUMIFY

Lumify is the only over-the-counter eye drop with low-dose brimonidine for the treatment of eye redness.

December 22, 2017

·

4 min read

BioMidwest

AIT Bioscience Recognized with Awards at Recent WRIB

WRIB (Workshop for Recent Issues in Bioanalysis) is an annual gathering of bioanalytical scientists from across the pharmaceutical industry spectrum.